Krka, d. d. (WSE:KRK)

Market Cap	28.70B
Revenue (ttm)	8.37B
Net Income (ttm)	1.62B
Shares Out	n/a
EPS (ttm)	52.70
PE Ratio	17.76
Forward PE	17.47
Dividend	35.03 (3.73%)
Ex-Dividend Date	Jul 22, 2025

Volume	24
Average Volume	285
Open	942.00
Previous Close	936.00
Day's Range	942.00 - 966.00
52-Week Range	570.00 - 988.00
Beta	0.49
RSI	77.54
Earnings Date	Nov 13, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR